BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Dow
US Army
Chubb
Argus Health
Cerilliant
Merck
Cantor Fitzgerald
Novartis

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,066,678

« Back to Dashboard

Summary for Patent: 6,066,678
Title: Process for removing bile salts from a patient and alkylated compositions therefor
Abstract:The invention relates to a method for removing bile salts from a patient in need thereof and compositions useful in the method. The method comprises administering to the patient a therapeutically effective amount of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer comprises the reaction product of polymers, or salts and copolymers thereof having amine containing repeat units, with at least one aliphatic alkylating agent and a crosslinking agent.
Inventor(s): Mandeville, III; W. Harry (Lynnfield, MA), Holmes-Farley; Stephen Randall (Arlington, MA)
Assignee: GelTex Pharmaceuticals, Inc. (Waltham, MA)
Application Number:09/388,876
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 6,066,678

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,066,678

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 184027 ➤ Subscribe
Austria 205508 ➤ Subscribe
Australia 2012399 ➤ Subscribe
Australia 2556095 ➤ Subscribe
Australia 2699095 ➤ Subscribe
Australia 6154396 ➤ Subscribe
Australia 694777 ➤ Subscribe
Australia 698752 ➤ Subscribe
Australia 7047994 ➤ Subscribe
Australia 706788 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKinsey
Healthtrust
Colorcon
Medtronic
US Army
Express Scripts
Citi
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot